T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Wegovy, the weight-loss brand of semaglutide, has a recommended maintenance dose of 2.4 mg. Novo ran the Phase III STEP UP ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

IT’S NOT ALL about shedding pounds and curbing hunger. GLP-1 drugs used for weight loss involve all kinds of side effects—good and not-so-good—that may or may not strike the average user.

A study by the Department of Veterans Affairs on the relationship between GLP-1 weight-loss ... Wegovy and Zepbound emerge regularly. “We tend to think of drugs as surgically designed to do only ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IT’S NOT ALL about shedding pounds and curbing hunger. GLP-1 drugs used for weight loss involve all ...

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on the body ... significant side-effect - and Ozempic and Wegovy became ...

GLP-1 drugs used for weight loss involve all kinds of side ... (Wegovy) for weight loss were more likely to develop erectile ...